This document discusses weaknesses in prescription drug programs for Medicare, Medicaid, and other government health plans. It notes that prescription drug abuse and fraud are areas of concern, as they drain funds from these programs. The document advocates including strategies to address these issues as part of ongoing efforts to improve the sustainability of Medicare and Medicaid.